个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Expert Consensus on the Clinical Application of Oral Small-molecule Antiviral Drugs Against COVID-19

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ CSCD-C ◇ 卓越：高起点新刊 ◇ ESCI ◇ 中华系列

作者：
Zhong, Nanshan[1,*1] * ; Li, Shiyue[1,2] ; Tang, Xiaoping[3] ; Wang, Guiqiang[4] ; Wang, Minggui[5] ; Yang, Zifeng[1] ; Zheng, Jinping[1] ; Cai, Shaoxi[6] ; Cao, Zhaolong[7] ; Chen, Xin[8] ; Cheng, Linling[1] ; Guo, Yubiao[9] ; Jiang, Shanping[10] ; Ju, Chunrong[1] ; Lai, Guoxiang[11] ; Li, Shiyue[1,2] ; Liang, Zhenyu[1,38] ; Sun, Ruilin[12] ; Wang, Lingwei[13] ; Wen, Fuqiang[14] ; Xu, Jinfu[15] ; Ye, Feng[1] ; Yin, Yan[16] ; Yuan, Bing[17] ; Zhan, Yangqing[1,38] ; Zhang, Jing[18] ; Zhang, Xiaoju[19] ; Zheng, Jinping[1] ; Li, Xin[20] ; Li, Yueping[21] ; Liu, Xiaoqing[1] ; Yu, Tao[22] ; Hou, Jinlin[23] ; Huang, Chaolin[24] ; Lin, Bingliang[25] ; Lin, Ling[26] ; Lu, Hongzhou[27] ; Mao, Qing[28] ; Peng, Jie[23] ; Ren, Hong[29] ; Tang, Xiaoping[3] ; Wang, Guiqiang[4] ; Wang, Minggui[5] ; Wu, Hao[30] ; Xiang, Tianxin[31] ; Zeng, Wending[32] ; Zhuo, Chao[32] ; Chen, Yanfang[33] ; Ding, Yanhua[34] ; Li, Yongmei[35] ; Wei, Li[36] ; Zhong, Honglan[37] ; Zou, Shangrong[33] ; Yang, Zifeng[1] ; Jiang, Mei[1] ; Liang, Zhenyu[1,38] ; Zhan, Yangqing[1,38] ; Zhang, Dongying[38] ; Wang, Mingdie[38] ;
机构： [1]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Guangzhou, Peoples R China [2]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Resp Hlth Res Inst, Guangzhou, Peoples R China [3]Guangzhou Med Univ, Affiliated Hosp 8, Dept Infect Dis, Guangzhou, Peoples R China [4]Peking Univ First Hosp, Dept Infect Dis, Beijing 100034, Peoples R China [5]Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai, Peoples R China [6]Southern Med Univ, Nanfang Hosp, Dept Resp Med, Guangzhou, Peoples R China [7]Peking Univ, Peoples Hosp, Dept Resp Med, Beijing, Peoples R China [8]Southern Med Univ, Zhujiang Hosp, Dept Resp Med, Guangzhou, Peoples R China [9]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Guangzhou, Peoples R China [10]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Resp Med, Guangzhou, Peoples R China [11]Fujian Univ Tradit Chinese Med, Affiliated Peoples Hosp 2, Dept Resp & Crit Care Med, Fuzhou, Peoples R China [12]Peking Univ, Shenzhen Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China [13]Shenzhen Peoples Hosp, Dept Resp & Crit Care Med, Shenzhen, Peoples R China [14]Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu, Peoples R China [15]Tongji Univ, Shanghai Lung Hosp, Shanghai, Peoples R China [16]China Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Shenyang, Peoples R China [17]First Peoples Hosp Yunnan Prov, Dept Resp & Crit Care Med, Kunming, Yunnan, Peoples R China [18]Fudan Univ, Zhongshan Hosp, Dept Resp & Crit Care Med, Shanghai, Peoples R China [19]Henan Prov Peoples Hosp, Dept Resp Med, Zhengzhou, Peoples R China [20]Guangdong Prov Peoples Hosp, Emergency Dept, Guangzhou, Peoples R China [21]Guangzhou Med Univ, Affiliated Hosp 8, Infect Dept ICU, Guangzhou, Peoples R China [22]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Emergency Dept, Guangzhou, Peoples R China [23]Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Peoples R China [24]Jinyintan Hosp, Dept Thorac Surg, Wuhan, Peoples R China [25]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Peoples R China [26]Sanya Cent Hosp, Dept Cardiol, Sanya, Peoples R China [27]Shenzhen Third Peoples Hosp, Dept Infect Dis, Shenzhen, Peoples R China [28]Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China [29]Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Chongqing, Peoples R China [30]Capital Med Univ, Beijing Youan Hosp, Dept Infect & Immunol, Beijing, Peoples R China [31]Nanchang Univ, Affiliated Hosp 1, Publ Hlth Med Ctr, Nanchang, Jiangxi, Peoples R China [32]Guangzhou Med Univ, Affiliated Hosp 1, Dept Infect, Guangzhou, Peoples R China [33]Guangzhou Med Univ, Affiliated Hosp 8, Dept Pharm, Guangzhou, Peoples R China [34]Jilin Univ, Bethune Hosp 1, Dept Pharm, Changchun, Peoples R China [35]Guangzhou Med Univ, Affiliated Hosp 5, Dept Pharm, Guangzhou, Peoples R China [36]Guangzhou Med Univ, Affiliated Hosp 1, Dept Pharm, Guangzhou, Peoples R China [37]Guangzhou Chest Hosp, Dept Pharm, Guangzhou, Peoples R China [38]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Resp Hlth Inst, Guangzhou, Peoples R China
出处：
DOI： 10.1097/ID9.0000000000000139
ISSN：

关键词： Coronavirus infections Antiviral therapy Small molecule drugs Early stage Expert consensus

摘要：
Although COVID-19 no longer constitutes a "public health emergency of international concern", which still has being spreading around the world at a low level. Small molecule drugs are the main antiviral treatment for novel coronavirus recommended in China. Although a variety of small-molecule antiviral drugs against COVID-19 have been listed in China, there is no specific drug recommendation for special populations. Society of Bacterial Infection and Resistance of Chinese Medical Association, together with the National Clinical Research Center for Respiratory Disease, and the National Center for Respiratory Medicine, organized domestic experts in various fields such as respiratory, virology, infection, critical care, emergency medicine and pharmacy to release Expert Consensus on the Clinical Application of Oral Small-Molecule Antiviral Drugs against COVID-19. The main content of this consensus includes the introduction of seven small-molecule antiviral drugs against COVID-19, focusing on the drug recommendations for 14 special groups such as the elderly, patients with complicated chronic diseases, tumor patients, pregnant women, and children, and providing suggestions for clinicians to standardize drug use.

基金：
Emergency Key Program of Guangzhou Laboratory [EKPG21-06]; Macao Science and Technology Development Fund [0022/2021/A1]; Young Top Talent of Science and Technology Innovation Department of Guangdong Province [2021TQ060189]; National Administration of Traditional Chinese Medicine's Interdisciplinary Innovation Team Project [ZYYCXTU-D-202201]
语种：
外文
WOS：
第一作者：
第一作者机构： [1]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Guangzhou, Peoples R China [*1]Guangzhou Med Univ, Guangzhou Inst Resp Hlth, Affiliated Hosp 1,State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis,Natl Ctr Resp Med, Guangzhou 510120, Peoples R China
通讯作者：
通讯机构： [1]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Guangzhou, Peoples R China [*1]Guangzhou Med Univ, Guangzhou Inst Resp Hlth, Affiliated Hosp 1,State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis,Natl Ctr Resp Med, Guangzhou 510120, Peoples R China
推荐引用方式(GB/T 7714)：
Zhong Nanshan,Li Shiyue,Tang Xiaoping,et al.Expert Consensus on the Clinical Application of Oral Small-molecule Antiviral Drugs Against COVID-19[J].INFECTIOUS DISEASES & IMMUNITY.2024,4(4):158-169.doi:10.1097/ID9.0000000000000139.
APA：
Zhong, Nanshan,Li, Shiyue,Tang, Xiaoping,Wang, Guiqiang,Wang, Minggui...&Wang, Mingdie.(2024).Expert Consensus on the Clinical Application of Oral Small-molecule Antiviral Drugs Against COVID-19.INFECTIOUS DISEASES & IMMUNITY,4,(4)
MLA：
Zhong, Nanshan,et al."Expert Consensus on the Clinical Application of Oral Small-molecule Antiviral Drugs Against COVID-19".INFECTIOUS DISEASES & IMMUNITY 4..4(2024):158-169

相关文献

[1]抗新型冠状病毒小分子药物临床应用专家共识 [2]Systematically integrative analysis identifies diagnostic and prognostic candidates and small-molecule drugs for lung adenocarcinoma [3]Expert consensus for PVCR in severe, rigid and angular spinal deformity treatment: The Kunming consensus. [4]Molecular diagnosis and treatment of meningiomas: an expert consensus (2022) [5]Expert consensus on dental caries management [6]International expert consensus on the management of bleeding during VATS lung surgery [7]Chinese expert consensus on the construction of the fluoroless cardiac electrophysiology laboratory and related techniques [8]Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou). [9]The Chinese Expert Consensus on Evaluation of Coma after Cardiopulmonary Resuscitation [10]The Chinese Association for the Study of Pain (CASP): Expert Consensus on the Cervicogenic Headache

资源点击量：86908 今日访问量：1 总访问量：707 更新日期：2025-03-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持：重庆聚合科技有限公司 地址：云南省昆明市西山区金碧路157号